Bell HK, Ormerod AD. Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors. Br J Dermatol 2009; 160:7258. Brouwers MC, Kho ME, Browman GP et al. AGREE II: advancing guideline ... General Medicine eJournal, 1 month ago
1 images for "zs associate"
Saint Luke's Mid America Heart Institute cardiologist presents findings at American Heart Association Scientific Meeting, results simultaneously published in JAMA Kansas City, Mo (PRWEB) November 17, 2014 Mikhail N. Kosiborod, M.D., ...MySanAntonio, 1 month ago ZS PHARMA : Clinical Trial Indicates Promising Results for Potential New Treatment for Hyperkalemia 4 Traders, 1 month ago
More from: PRWeb, PRWeb...and 6 other sources
PUBLIC RELEASE DATE: 17-Nov-2014 Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than ...EurekAlert!, 1 month ago Zirconium Cyclosilicate Lowers High Potassium Levels Associated With Potentially Lethal Cardiac Arrhythmias MedIndia, 1 month ago
Study Data from GlaxoSmithKline Update Understanding of Breast Cancer (Association of phosphatase and tensin homolog low and phosphatidylinositol...
Study Data from GlaxoSmithKline Update Understanding of Breast Cancer (Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor ...) By ...4 Traders, 2 weeks ago
ZS Pharma Announces Late Breaking Presentation of Phase 3 HARMONIZE (ZS004) Trial Results in Patients With Hyperkalemia at AHA Annual Meeting
Additional ZS003 Phase 3 Presentations Also Featured at American Heart Association (AHA) Annual Scientific Meeting COPPELL, Texas, Nov. 6, 2014 (GLOBE NEWSWIRE) -- ZS Pharma (Nasdaq:ZSPH), a biopharmaceutical company developing novel treatments ...BizWire Express, 1 month ago ZS Pharma announces publication of results from phase 3 study of ZS-9 in patients with hyperkalemia Medical News Today, 3 weeks ago ZS Pharma reports results from Phase III study of ZS-9 in patients with hyperkalemia Pharmaceutical Business Review, 3 weeks ago ZS PHARMA : Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine 4 Traders, 4 weeks ago
More from: Town Hall, Stock Nod...and 43 other sources
According to a study published in the Canadian Medical Association Journal (CMAJ), common antibiotic treatments like amoxicillin and amocicillin-clavulanic acid, can result in diarrhea and candidias, although harms may be underreported. ...Noodls, 1 month ago Diarrhea and candidiasis associated with common antibiotic amoxicillin EurekAlert!, 1 month ago
CHICAGO — Treatment with sodium zirconium cyclosilicate was associated with rapid and sustained reductions in serum potassium compared with placebo in patients with hyperkalemia. The phase 3, double blind, multicenter HARMONIZE trial included ...Orthopedics Today, 1 month ago
FierceMedicalDevices caught up with Pratap Khedkar, managing principal at ZS Associates, which provides sales and marketing consulting to 18 of the 20 top medical devices companies and many Big Pharma players. He spoke at length about the Sunshine ...FierceMedicalDevices, 1 month ago
The NFU is reminding the public of the risks associated with sky lanterns, and urging them to think twice about releasing them into the air. Over the New Year, the successful Love your Countryside campaign will highlight the issue of how dangerous ...NFU Online, 1 month ago
Share Developed in partnership with the RSA, the Ideas Lab at our 2014 Annual Conference was an opportunity for delegates to explore organisational change, learning both from one another, but also from people leading change outside the sector ...National Housing Federation, 1 month ago
on your WebpageAdd Widget >Get your members hooked!